Healthcare
Sustainability woes threaten Asia’s universal healthcare schemes
Indonesia has accumulated a deficit of US$302m in 2015.
Sustainability woes threaten Asia’s universal healthcare schemes
Indonesia has accumulated a deficit of US$302m in 2015.
Q&M Dental Group’s third-largest China deal could open larger opportunities, analysts say
It will buy stakes in a dental research firm for SGD13.8m.
Here’s why Raffles Med has no problem securing top medical talent in China
They rely on their group practice model.
Chart of the Week: Check out how healthcare spending is expected to boom
It’s expected to rise by 7.7% by 2020.
Can IHH Healthcare withstand rising cost pressure?
Staff costs have skyrocketed to unprecedented levels.
Q&M Dental Group floors the gas pedal on growth in Singapore
The city-state is the firm’s core market.
Here’s why Riverstone Holdings is well positioned to withstand demand headwinds
It’ll be boosted by favorable forex movement.
Open season for pharma firms as Vietnam launches public immunisation programme
The programmes will remove a major roadblock for pharmaceutical firms.
Consumers and doctors disagree regarding access to electronic health records, says survey
82% of consumers in Singapore want full access.
Is Singapore's medical tourism sector losing its lustre?
Modernisation at ASEAN hospitals is a key threat.
Demand for respiratory treatments in China to remain high, say analysts
CRDs account for 13% of chronic disease-driven deaths.
Chart of the Week: Healthcare infrastructure in Singapore, HK, under immense strain
Some hospitals are exceeding 100% occupancy.
Telecare will shape pharmaceutical opportunities in the Asia-Pacific region: BMI
Singapore and Hong Kong will benefit the most, they said.
Indonesia searches for the “missing middle” as UHC deadline looms
Over 100m people are still not covered.
Chart of the Week: Bright future ahead for Thailand’s private healthcare providers
Thanks to its medical tourism hub status.
This Asian country beats Singapore in terms of support for biopharma innovation
Singapore is ranked fourth worldwide.
Raffles Med’s Q1 profits inch up 3.7% to $15.5m
On back of increased staff expenses.